Buyer's Guide

Contact | Print version | PDF version | Recommend company

Portrait
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena’s most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena’s broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc. Arena Pharmaceuticals® and Arena® are registered service marks of the company. "APD” is an abbreviation for Arena Pharmaceuticals Development.

Industrial Sectors

Pharmacy